Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on the Utility of Tafasitamab
Episode S26 · Ep 379 15 min 59s

Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on the Utility of Tafasitamab

Featuring an interview with Dr Matthew Lunning, including the following topics:

  • Tafasitamab for follicular lymphoma (0:00)
  • frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)

CME information and select publications

Community discussion